metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet
- RxCUI
- 2709491
- RxNorm name
- metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet
- Display name
- metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet
- Full name
- metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JANUMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | b55ee3d9-7f0b-4dd9-9213-fbc69f09f567 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 2709491 |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Apotex Corp. | 950613e2-e959-6b57-e172-251ddc53c64c | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 2709491 |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Sandoz Inc | a0fcdc08-0afc-4912-a126-3efea6bc8c61 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 2709491 |
| JANUMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | d19c7ed0-ad5c-426e-b2df-722508f97d67 | 2025-03-25 | Boxed warning, Warnings, Adverse reactions | 2709491 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d19c7ed0-ad5c-426e-b2df-722508f97d67 | metFORMIN hydrochloride 500 MG / SITagliptin phosphate 50 MG Oral Tablet [PSN] · metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet [SCD] | 2 | 60 | These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET. JANUMET ® (sitagliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2007 | 20250325 |
| b55ee3d9-7f0b-4dd9-9213-fbc69f09f567 | metFORMIN hydrochloride 500 MG / SITagliptin phosphate 50 MG Oral Tablet [PSN] · metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet [SCD] | 2 | 11 | These highlights do not include all the information needed to use JANUMET safely and effectively. See full prescribing information for JANUMET. JANUMET ® (sitagliptin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2007 | 20230724 |
| 950613e2-e959-6b57-e172-251ddc53c64c | metFORMIN hydrochloride 500 MG / SITagliptin phosphate 50 MG Oral Tablet [PSN] · metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use SITAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLETS. SITAGLIPTIN AND METFORMIN HYDROCHLORIDE tablets for oral use. Initial U.S. Approval: 2007 | 20260414 |
| a0fcdc08-0afc-4912-a126-3efea6bc8c61 | metFORMIN hydrochloride 500 MG / SITagliptin phosphate 50 MG Oral Tablet [PSN] · metformin hydrochloride 500 MG / sitagliptin phosphate 50 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use SITAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLETS. SITAGLIPTIN and METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2007 | 20250901 |